This CME activity is expired. For more CME activities, visit CMEInstitute.com.
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders
Article Abstract
During the reproductive years, depression is common in women, and many face treatment decisions during pregnancy. Possible risks of untreated maternal depression include increased risk of relapse and postpartum depression, all the serious risks associated with the untreated disorder in nonpregnant women, and obstetrical complications. Data on teratogenic risks of antidepressant use are inconsistent, but these risks should be taken into consideration. Overall, treatment should be individually tailored, and nonpharmacologic options may be appropriate.
From the Editors
Vol 87 • 2026 • Number 1
Read the Current Issue
ASCP Corner
Rethinking Amisulpride: Could N-Methylation Result in a New and Even Better Antipsychotic?
Original Research
How Many Criteria Should be Required to Define the DSM-5 Mixed Features Specifier in Depressed Patients?
Meta-Analysis
Effectiveness of Peer-Administered Interventions for Perinatal Depression or Anxiety
Original Research
Innovation in Psychiatric Drug Development: A Quantitative Analysis of FDA-Approved Psychiatric Drugs, 2012–2024
Brief Report
Exercise Reduces Dysphoria in Clinical High-Risk for Psychosis: A Randomized Controlled Trial
Clinical and Practical Psychopharmacology
Pregabalin in Pregnancy: Major Congenital Malformations, Other Birth Outcomes, and Neurodevelopmental Outcomes
Consensus Report on XT Use in Practice
Read the full report